Tim Watkins - Apr 28, 2025 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role: CMO & Head of Development
Signature: /s/ Peter Slover, Attorney-in-Fact
Stock symbol: CTNM
Transactions as of: Apr 28, 2025
Transactions value $: $0
Form type: 3
Date filed: 4/28/2025, 04:16 PM
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney